FdaApplication
NDA 050168
Identifiers
- fda_app_no: NDA050168
Properties
| Property | Value |
|---|---|
| applicant_name | MONARCH PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 1984-05-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CORTISPORIN | BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | OINTMENT;TOPICAL |
1 product